September 1, 2020 Kerry ClemEmployment Agreement • September 9th, 2021 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 9th, 2021 Company Industry JurisdictionWe are delighted to present this letter agreement (“Agreement”), setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Executive Vice President, Sales, Market Access and Operations. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of September 1, 2020 (the "Effective Date").
September 1, 2017Employment Agreement • March 9th, 2018 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 9th, 2018 Company Industry JurisdictionWe are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Technology Officer and Site Head. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of September 1, 2017 (the "Effective Date"). We note that you previously entered into an employment agreement with Civitas Therapeutics, Inc. (“Civitas”), a wholly-owned subsidiary of the Company, and upon the Effective Date the existing Civitas employment agreement will terminate and be superseded in its entirety by this letter agreement.
September 1, 2017Employment Agreement • March 1st, 2018 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 1st, 2018 Company Industry JurisdictionWe are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Technology Officer and Site Head. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of September 1, 2017 (the "Effective Date"). We note that you previously entered into an employment agreement with Civitas Therapeutics, Inc. (“Civitas”), a wholly-owned subsidiary of the Company, and upon the Effective Date the existing Civitas employment agreement will terminate and be superseded in its entirety by this letter agreement.
As of July 1, 2016Employment Agreement • November 7th, 2016 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 7th, 2016 Company Industry JurisdictionWe are delighted to present this letter agreement, setting out the terms of your employment with Acorda Therapeutics, Inc. (the "Company") as Chief Medical Officer. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of July 1, 2016 (the "Effective Date").
June 8, 2015Employment Agreement • August 7th, 2015 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionWe are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Medical Officer. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of June 8, 2015 (the "Effective Date").
June 8, 2015 Lauren Sabella Fairfield, CT 06825 Dear Lauren:Employment Agreement • August 7th, 2015 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionWe are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Commercial Officer. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of June 8, 2015 (the "Effective Date").
ContractEmployment Agreement • March 3rd, 2014 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 3rd, 2014 Company Industry Jurisdiction